Angelike Kefalas serves as Chief Business & Commercial Officer at Pinpoint Science overseeing commercial business operations, sales & marketing. She has more than 25 years of biotechnology and diagnostic experience in business development, corporate strategy, sales & marketing, and finance across large and small biopharmaceutical companies.

​

Ms. Kefalas began her career as an Analyst writing industry reports on companies and emerging health products prior to transitioning into emerging biotechnology companies – including Abbott, Nektar Therapeutics, Tethys Bioscience, XOMA – where she launched 7 FDA products and spearheaded several major pharmaceutical collaborations with companies including Pfizer, Roche, and Allergan.

 

Over the decades of experience in commercial roles Angelike has had escalating roles and responsibilities, holding senior positions, overseeing teams of 20 responsible for business development, licensing, marketing, sales, commercial operations, partnerships, collaborations, equity investments, joint ventures, and mergers and acquisitions.

 

Prior to Pinpoint Science, Ms. Kefalas served as Head of Global Product Launch, Marketing & Communications where she launched the company's 1st product and oversaw a range of business operations including commercial partnerships, corporate strategy and corporate communications.

 

Ms. Kefalas holds an MBA from Columbia Business School, NY.  She currently serves as a commercial and business advisor and consultant and sits on several Advisory Boards at diagnostic, med device and digital health start-ups.